Our recent results revealed an unexpected link between Toll-like receptors (TLRs) and some forms of histiocytosis, a disease characterized by expansion of dendritic cells or monocyte/macrophages (1, 2). TLRs serve as pathogen sensors in monocytes and 3 macrophages. TLR7 and 8 respond to pathogen-derived RNA (3, 4) and their excessive activation drives macrophage activation syndrome in mice (5-8), although underlying mechanisms are not completely understood. The structures of TLR7 and 8 indicate that nucleosides act on TLR7 and 8 (9-11). TLR7 binds to guanosine (Guo) or 2'-deoxyguanosine (dGuo) as well as to uridine (Uri)-containing ORN, whereas TLR8 interacts with Uri and purine-containing ORN. Very interestingly, abnormal nucleoside storage is known to cause some monogenic forms of histiocytosis, although molecular mechanisms behind were not understood. Our recent findings on the interaction between TLR7/8 and nucleosides could be applicable to such human diseases.
3 macrophages. TLR7 and 8 respond to pathogen-derived RNA (3, 4) and their excessive activation drives macrophage activation syndrome in mice (5) (6) (7) (8) , although underlying mechanisms are not completely understood. The structures of TLR7 and 8 indicate that nucleosides act on TLR7 and 8 (9) (10) (11) . TLR7 binds to guanosine (Guo) or 2'-deoxyguanosine (dGuo) as well as to uridine (Uri)-containing ORN, whereas TLR8 interacts with Uri and purine-containing ORN. Very interestingly, abnormal nucleoside storage is known to cause some monogenic forms of histiocytosis, although molecular mechanisms behind were not understood. Our recent findings on the interaction between TLR7/8 and nucleosides could be applicable to such human diseases.
It was previously known that RNA degradation in endosome/lysosomes proceeds up to nucleosides, which are transported to the cytoplasm for further degradation into the end-metabolite uric acid. SLC29A3, a lysosomal membrane protein abundantly expressed in monocyte/macrophages, mediates nucleoside transport across the lysosomal membranes (12) . Mutations of the SLC29A3 gene cause monogenic diseases including H syndrome, Faisalabad Histiocytosis, pigmented hypertrichosis with insulin-dependent diabetes mellitus (PHID) syndrome, and familial Rosai-Dorfman disease (13) (14) (15) . These SLC29A3 disorders are characterized by histiocytosis due to nucleoside storage in endosome/lysosomes (13) (14) (15) . However, mechanisms by which nucleoside storage causes histiocytosis have not been understood. We hypothesized that nucleosides such as Guo act on TLR7 in SLC29A3 disorders to drive histiocytosis.
Slc29a3 -/-and Tlr7 -/-mice were generated and crossed with each other to generate Slc29a3 -/-Tlr7 -/-mice (Fig. S1, S2 ). The organs of Slc29a3 -/-mice were examined by Liquid Chromatography-Mass Spectrometry (LC-MS) to evaluate nucleoside accumulation. While tissue levels of Guo and dGuo were difficult to detect in wild-type mice, we found them in the spleen of lysosomal nucleoside transporter-deficient Slc29a3 -/-mice (Fig. 1A, Fig. S3 ). As human and mouse TLR7s respond to Guo and dGuo, but not other nucleosides (9) , Guo and dGuo that accumulated in Slc29a3 -/-mice may act on TLR7. Consistent with the previous report (16) , spleens of Slc29a3 -/-mice were large due to increases in cell number (Fig. 1B, Fig. S4A ). Concerning cell typespecific changes in spleen and peripheral blood, increases in the percentages were restricted to CD11b + Ly6G -monocyte/macrophages ( (Fig. 1E , F, S4H) (17) . We hereafter describe CD11b + Ly6C lo FcγRIV hi cells accumulated in Slc29a3 -/-mice as patrolling monocytes/macrophages. These changes were totally dependent on TLR7, as demonstrated in Slc29a3 -/-Tlr7 -/-mice ( Fig. 1B-F, S4 ). These results indicate that TLR7 drives histiocytosis in Slc29a3 -/-mice.
Although accumulation of Guo and dGuo in increased patrolling monocyte/macrophages in spleen suggests that TLR7 drives histiocytosis in a cellautonomous manner (Fig. 1G) , it was possible that TLR7-dependent cytokine production promotes histiocytosis. So, we determined cytokine levels in sera of Slc29a3 −/− mice. Consistent with a previous report (16) , proinflammatory cytokines were not induced in Slc29a3 -/-mice. Serum levels of proinflammatory cytokines such as IFN-α, IFN-β, IFN-γ, IL-1β, IL-6, IL-17A, IL-23, and TNF-α were not detectable as judged by antibody arrays and/or ELISA ( Fig. S5A-C) . TLR7-dependent increases in serum IL-12 p40 and CXCL13 in Slc29a3 -/-mice were confirmed in ELISA (Fig. S5D, E ). Despite the 5 elevated level of IL-12 p40, its active form, IL-12 p70, were not altered (Fig. S5F) .
Although TLR7-mediated activation can result in inflammatory cytokine production, this was not the case with TLR7 activation by nucleosides in Slc29a3 −/− mice.
Patrolling monocytes are known to clear damaged cells (17) . So, we labelled and injected dying thymocytes to wild-type and Slc29a3 -/-mice, and found that nucleosideladen patrolling monocytes/macrophages in the spleen of Slc29a3 -/-mice had phagocytic activity ( Fig. 2A) . Furthermore, professional phagocytes such as thioglycollate-elicited peritoneal exudate cells (PECs) and bone marrow-derived macrophages (BM-MCs) stored nucleosides (Fig. S6A, B) , probably because they engulfed cell corpses during induction with thioglycollate in vivo or M-CSF in vitro. In contrast, less phagocytic cells such as B cells and bone marrow-derived pDCs had much less nucleoside storage (Fig. S7 ). Of note, dG storage was hard to detect in these poorly phagocytic cells. These results suggest that phagocytosis promotes nucleoside storage in patrolling monocytes/macrophages.
To further study phagocytosis-mediated nucleoside storage, we exposed BM-MCs to dying thymocytes (Fig. 2B, Fig. S8 ). Accumulation of nucleosides was detected as early as at 8 h and peaked at 24 h after treatment with cell corpses. At 48 h, the levels of Guo and dGuo were decreased to steady state in wild-type BM-MCs, but remained high in Slc29a3 -/-BM-MCs. Very interestingly, dG storage was detected even in wild-type BMMCs, suggesting that an excessive number of cell corpses can induce transient dG accumulation in lysosomes, despite SLC29A3-mediated clearance. TLR7 activation by nucleosides might occur in massive tissue damages even in wild-type monocytes/macrophages. In contrast to cell corpse phagocytosis, SRBC engulfment did 6 not increase nucleosides (Fig. 2C, Fig. S9 ). Given that SRBCs do not have nuclei, nuclear DNA from cell corpses might be a major source of accumulated nucleosides.
Consistent with this, DNA-derived nucleosides such as dGuo, deoxyadenosine (dAdo), deoxycytidine (dCyt), and thymidine (Thy) were accumulated only after cell corpse phagocytosis and only in Slc29a3 -/-BM-MCs (Fig. 2C, Fig. S9 ). Guo was not apparently increased after cell corpse phagocytosis. Stored Guo might be of endogenous origin.
As cell corpse engulfment induced nucleoside storage, we next focused on phagosomes in Slc29a3 -/-macrophages. Phagosomes containing cell corpses seemed to be similarly formed in Slc29a3 -/-BM-MCs (Fig. S10, arrowhead) . Recruitment of LAMP-2 + lysosomes to cell corpses was found to be increased in Slc29a3 -/-macrophages ( Fig. 2D) , suggesting that phagolysosomal fusion was enhanced in a TLR7-dependent manner in Slc29a3 -/-mice. Because TLR7 in steady state BM-MCs was localized in LAMP2 + lysosomes (Fig. S11) , TLR7 movement to dying cellcontaining phagosomes was also increased in Slc29a3 -/-BM-MCs (Fig. 2E) . Given that TLR activation increases phagolysosomal fusion in phagosome-autonomous manner (18) , our results suggest that TLR7 in the phagosomes of Slc29a3 -/-BM-MCs was aberrantly activated, leading to additional phagolysosomal fusion. As TLR7 recruitment was lower in wild-type monocyte/macrophages, aberrant TLR7 activation by cell corpses in phagosomes would not have occurred, suggesting that SLC29A3 is localized in TLR7-containing phagosomes.
We next focused on molecular mechanisms by which TLR7 drives histiocytosis. We studied in vitro survival of splenic monocyte/macrophages. CD11b + spleen cells from wild-type, Slc29a3 -/-, and Slc29a3 -/-Tlr7 -/-mice failed to survive in vitro culture (Fig.   3A ). In the presence of M-CSF at 1-5 ng/ml, concentrations comparable to serum M-CSF (Fig. 3B) , Slc29a3 -/-CD11b + cells survived in vitro culture, but not wild-type or Slc29a3 -/-Tlr7 -/-CD11b + cells (Fig. 3A) . These results suggest that TLR7-dependent hyper-responsiveness to M-CSF drives histiocytosis in Slc29a3 -/-mice. Serum levels of M-CSF and CD115 expression have been reported to be increased in Slc29a3 -/-mice (16) . These increases in our Slc29a3 -/-mice were dependent on TLR7 (Fig. 3B, 3C ).
We here show that SLC29A3 negatively regulates TLR7 activation by transporting nucleosides from lysosomes to the cytoplasm (Fig. S12 ). When the transporting activity of SLC29A3 is impaired, stored nucleosides drive histiocytosis by promoting M-CSFdependent survival and proliferation of monocyte/macrophages in a TLR7-dependent manner. Taken together with previous reports showing that TLR7 and TLR8 bind and respond to nucleosides (9, 11) , SLC29A3 disorders in mice are caused by TLR7 responses to nucleosides. TLR7 was localized in LAMP-2 + compartment and recruited to phagosomes containing cell corpses due to constitutive lysosomal fusion. Very importantly, lysosomal fusion was increased in Slc29a3 -/-macrophages in a TLR7-dependent manner. Given that phagolysosomal fusion is activated by phagosomal TLRs in phagosomeautonomous manner (19) , phagosomal TLR7 is likely to be activated to promote further lysosomal fusion in Slc29a3 -/-macrophages. In addition to phagosomal maturation, TLR7 activation in phagosomes is likely to drive histiocytosis. Most importantly, TLR7 responses to nucleosides in Slc29a3 -/-mice drove cell proliferation/survival without any apparent inflammation. TLR7 might activate two distinct types of responses, 8 proinflammatory and pro-histiocytosis responses. Monocytosis with thrombocytopenia is reported in mice where TLR7 is constitutively activated by its over-expression or altered trafficking (5, 6) . These phenotypes are understood as macrophage activation syndrome (MAS), a complication of autoimmune diseases and infections (8) . TLR7-dependent pro-histiocytosis responses might contribute to MAS.
In conclusion, we here show that TLR7 drives histiocytosis in SLC29A3 disorders.
Further study needs to focus on the role of TLR7 in histiocytosis caused by viral infection or autoimmune diseases. TLR7 might be a target for therapeutic intervention in histiocytosis. 
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Methods
Generation of Slc29a3 -/-and Tlr7 -/-Mice SLC29A3 Knock-out (Slc29a3 -/-) and TLR7 Knock-out (Tlr7 -/-) mice were generated using a CRISPR/CAS system. gRNA target sites of Slc29a3 and Tlr7 genes were determined by CRISPRdirect software (http://crispr.dbcls.jp/). 5'-agcttcttgatggttactcg-3' and 5'-gaacagttggccaatctctc-3' sequences were used for construction of Slc29a3 -/-and Tlr7 -/-mice, respectively. These gRNA target sequences were cloned into the BbsI site of pKLV-U6 gRNA (BbsI)-PGKpuro2ABFP Vector (Addgene plasmid 50946), and gRNAs were synthesized from the constructed vector in vitro using MEGAshortscript T7 Transcription Kit (ThermoFisher Scientific, MA, USA). In addition, hCAS9 mRNA was synthesized from the hCAS9 sequence in pX458 (Addgene plasmid 48138) in vitro using mMESSAGE mMACHIN T7 ULTRA Transcription Kit (ThermoFisher Scientific). To construct Slc29a3 -/-Tlr7 -/-double knock-out mice, gRNAs (50ng/μl) to target Slc29a3 and Tokyo, Japan), and one candidate male mouse having both knock-in alleles in SLC29A3 gene and a frame shift mutation in TLR7 gene was chosen for mating with wild-type B6 female mice. Obtained (wild-type B6/dKO) F1 mice were used for the construction of both Slc29a3 -/-and Slc29a3 -/-Tlr7 -/-mice. The sequences of mutation allele in Slc29a3 -/-and Tlr7 -/-mice was confirmed by the direct sequencing performed by FASMAC (Kanagawa, Japan).
Mice
Wild-type C57BL/6 mice were purchased from Japan SLC, Inc. (Shizuoka, Japan). All animals were housed in specific pathogen-free facilities at the Institute of Medical Science, University or Tokyo (IMSUT). All animal experiments were approved by the Institutional Animal Care and Use Committee in the IMSUT.
Reagents
Guanosine (Guo) and Uridine (Uri) were purchased from Wako Pure Chemical Industries (Osaka, Japan). Adenosine (Ado), Cytidine (Cyt) and Thymidine (Thy) were purchased from MP Biomedicals (Santa Ana, CA, USA). 2'-Deoxyadenosine (dAdo) and 2'-Deoxycytidine (dCyt) were purchased from Sigma-Aldrich Japan (Tokyo, Japan). 
Platelet and Leukocyte Count
Platelet, leukocyte number in PBMC was analyzed by automatic hematology analyzer, Statistical significance was determined using two-sided t tests.
Electron Microscopy
5 × 10 7 Heat killed thymocytes were added to 5 × 10 6 mouse BM-macrophages (BMMCs) in 10cm dishes and cultured for 1hour. Then BM-MCs on plates were fixed in the solution containing 2.5% glutaraldehyde, 2% formaldehyde in 0.1M sodium phosphate buffer (pH 7.4) for 2hrs at room temperature. After fixation, tissues were rinsed and post-fixed in the 2% osmium tetroxide in the same buffer solution on ice. They were then washed, dehydrated in the graded series of ethanol and embedded in Epon 812 resin mixture (TAAB, Berks, UK). Semi-thin sections of about 0.7 micro-meter thickness were cut on a Reichert Ultracut N ultramicrotome, stained with 0.2% toluidine blue and examined under a Zeiss Axioskop microscope. Ultra-thin sections were cut, stained with uranyl acetate and lead citrate and examined with a HITACHI H-7500 electron microscope.
LC-MS Analysis (Cell Preparation)
The quantitative nucleoside analysis was performed with a LC-MS system equipped with a reversed-phase column (2.0 mm I.D. × 100 mmL) packed with Develosil C30 UG Samples (ca 1~100pmole nucleosides/40 μL) were loaded to a reversed phase column and eluted with a 30 min linear gradient from 2% to 12% acetonitrile in 10mM ammonium acetate buffer (pH 6.0) at a flow rate 100 μL/min. The eluate from the first 6 min was wasted automatically by switching a 3-way electric valve to remove guanidine hydrochloride from the system and was subsequently sprayed into a mass spectrometer 20 at 3.0 kV operating under the positive ion mode. The mass spectra were acquired at a mass resolution of 35,000 from m/z 200 to 305. Each nucleoside in the sample cells or tissues was quantitated from the peak height relative to that of the corresponding isotope labeled standard nucleoside. All LC-MS data were processed and analysed using Xcalibur (version 3.0.63, Thermo) and Excel 2013 (Microsoft).
Statistical Analysis
Statistical analysis to compare two conditions was performed using Two-tailed unpaired t test with Holm-Sidak correction. All data are presented as mean value ± standard deviation (s.d.). P<0.05 was considered statistically significant. *P < 0.05, **P < 0.01, ***P < 0.001. and G accumulate and act on TLR7, leading to further TLR7 recruitment to phagosomes and TLR7 activation. TLR7 activation in phagosomes drives histiocytosis.
